Crohn's disease risk factors

Revision as of 04:25, 12 August 2012 by Aditya Govindavarjhulla (talk | contribs) (Created page with "__NOTOC__ {{Crohn's disease}} {{CMG}} ==Overview== ==Risk Factors== Although the cause of Crohn's disease is not known, it is believed to be an [[autoimmunity|autoimmune disea...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Crohn's disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Crohn's Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Crohn's disease risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Crohn's disease risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Crohn's disease risk factors

CDC on Crohn's disease risk factors

Crohn's disease risk factors in the news

Blogs on Crohn's disease risk factors

Directions to Hospitals Treating Crohn's disease

Risk calculators and risk factors for Crohn's disease risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Risk Factors

Although the cause of Crohn's disease is not known, it is believed to be an autoimmune disease that is genetically linked. The highest relative risk occurs in siblings, affecting males and females equally. Smokers are three times more likely to get Crohn's disease.

Unlike the other major type of IBD, ulcerative colitis, there is no known medical or surgical cure for Crohn's disease.[1] Instead, a number of medical treatments are utilized with the goal of putting and keeping the disease in remission. These include 5-aminosalicylic acid (5-ASA) formulations (Pentasa capsules, Asacol tablets, Lialda tablets, Rowasa retention enemas), steroid medications, immunomodulators (such as azathioprine, mercaptopurine (6-MP), and methotrexate), and newer biological medications, such as infliximab (Remicade) and adalimumab (Humira).[2]Also in January 2008 the U.S. Food and Drug Administration approved a new biologic known as natalizumab (Tysabri) for both induction of remission and maintenance of remission in moderate and severe Crohns Disease.

References

  1. Al-Ataie, M Bashar (2005-10-04). "Ulcerative colitis". eMedicine. Retrieved 2006-07-02. Unknown parameter |coauthors= ignored (help)
  2. Podolsky, Daniel K. (2002). "Inflammatory bowel disease". New England Journal of Medicine. 346 (6): 417–29. PMID 12167685. Retrieved 2006-07-02. Unknown parameter |month= ignored (help)

Template:WH Template:WS